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Abstract
Background: Costa Rica, like other developing countries, is experiencing an increasing burden of
chronic conditions such as diabetes mellitus (DM), especially among its elderly population. This
article has two goals: (1) to assess the level of metabolic control among the diabetic population age
≥ 60 years old in Costa Rica, and (2) to test whether diabetic elderly patients of community health
centers differ from patients in other health care settings in terms of the level of metabolic control.
Methods: Data come from the project CRELES, a nationally representative study of people aged
60 and over in Costa Rica. This article analyzes a subsample of 542 participants in CRELES with self-
reported diagnosis of diabetes mellitus. Odds ratios of poor levels of metabolic control at different
health care settings are computed using logistic regressions.
Results: Lack of metabolic control among elderly diabetic population in Costa Rica is described as
follows: 37% have glycated hemoglobin ≥ 7%; 78% have systolic blood pressure ≥ 130 mmHg; 66%
have diastolic blood pressure ≥ 80 mmHg; 48% have triglycerides ≥ 150 mg/dl; 78% have LDL ≥ 100
mg/dl; 70% have HDL ≤ 40 mg/dl. Elevated levels of triglycerides and LDL were higher in patients
of community health centers than in patients of other clinical settings. There were no statistical
differences in the other metabolic control indicators across health care settings.
Conclusion: Levels of metabolic control among elderly population with DM in Costa Rica are not
that different from those observed in industrialized countries. Elevated levels of triglycerides and
LDL at community health centers may indicate problems of dyslipidemia treatment among diabetic
patients; these problems are not observed in other health care settings. The Costa Rican health
care system should address this problem, given that community health centers constitute a means
of democratizing access to primary health care to underserved and poor areas.
Background
Several Latin American countries are advancing quickly
through the epidemiologic transition. They are facing a
double epidemiologic burden, since the prevalence of
chronic illnesses is increasing and some infectious dis-
eases have not been completely eradicated [1-3]. Costa
Rica, one of the Latin American leaders in the epidemio-
logic transition, achieved a very fast reduction in the prev-
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alence of communicable diseases and malnutrition
thanks to improved access to primary health care [4].
However, this primary health care system is now strug-
gling with an increase in the aged population and in the
burden of chronic and degenerative diseases [2-5]. Adap-
tation to this new epidemiological profile may be harder
in developing countries than in the industrialized world
because of the great speed of changes and the relative scar-
city of economic resources of the population and of the
providers.
Diabetes mellitus (DM) is one of the illnesses with the
highest burden among Latin American elderly because
survivors of the cohorts born during the first half of the
20th century may be adopting nutritional and lifestyle
behaviors of the industrialized world [3,5-7], and at the
same time these cohorts experienced disadvantaged
health conditions during their younger years [3,8]. These
two circumstances are argued to be risk factors for the
development of DM [3]. In Costa Rica, the country with
the highest life expectancy in Latin America [4], death
rates due to DM in 2004 are 2.5 times the rates observed
in 1990 [9]. The prevalence of diabetes in 2000 among
people 20 years and above was 3.3% in Costa Rica,
according to official figures of the World Health Organi-
zation (WHO) [10]. It is also the illness with the highest
total hospitalization cost, and the second in outpatient
costs (after hypertension) for the Costa Rican public hos-
pital and clinic system [11]. Adequate management of
DM is becoming an important public health concern in a
country whose health care system needs to face the chal-
lenge of an increasing burden of chronic diseases.
Studying the burden of chronic diseases in Costa Rica is
also becoming important because of its demographic con-
text. The population is aging at a rapid pace. The popula-
tion age 60 and over will triple from 2000 to 2025, and its
share among the total population will increase from 8%
to 16%. Costa Rica is also one of the Latin American coun-
tries with the highest proportion of the elderly living in
rural areas (37%). Regarding ancestry, most Costa Rican
elderly can be classified as of "mixed ethnic origins",
descendants of a combination of ethnic backgrounds:
Europeans, indigenous groups, African blacks, and Chi-
nese immigrants. However, Costa Ricans see themselves
as "white" or "mestizo". Around 1% of the people age 60
and above classifies themselves as indigenous and less
than 2% as blacks, and these minorities are dispropor-
tionately located in the province of Limon, in the Carib-
bean coast. An important proportion of the black
community in Costa Rica descends from immigrants who
came to work on the railroad from Jamaica and Barbados
during the late part of the 19th century. From a demo-
graphic perspective, country of origin is more relevant
than race, given that 8% of the elderly population was
born abroad, especially in Nicaragua [9].
Although Costa Rica has a mixed health care system, most
of the services are provided through a network of hospi-
tals and clinics managed by a public institution-the Social
Security system. This system is in part responsible for the
high life expectancy levels of Costa Rica [12,13]. The
Social Security system is funded from deductions from the
payroll, and contributions by the employers and the Gov-
ernment. This is the so-called "contribution regime".
Workers that contribute to the System are entitled to
health insurance that allows them and their family to
receive free health care services and free medications at
any hospital, clinic or community health center run by the
Social Security system. Additionally, after a "means test",
the Government provides health insurance to poor people
who are not entitled to it through the "contribution
regime". This is the so-called "insurance by the State" or
the "non-contribution" regime. Data from the CRELES
sample show that the contribution regime covers around
80%; the non-contribution, 15%; and 5% are not insured.
There are no copayments for receiving health care. Finally,
there are also private hospitals, clinics, and physician
offices. People who seek services at these private health
care settings have to pay out-of-pocket not only for health
care but also for medication and laboratory tests. A new
market of private health insurance that caters to high
income families is starting to grow in Costa Rica. Interest-
ingly, there are people who use both sectors (e.g., people
go for outpatient visits at public clinics but pay out-of-
pocket for laboratory examination at private laboratories)
[14]. It is important to say also that most of the private
hospitals and clinics are located in the Metropolitan Area,
where the capital is, while community health centers, and
public clinics and hospitals are spread over the Costa
Rican territory.
A recent health sector reform, that started around 1995,
achieved further advances in reducing child and adult
mortality [13]. One of the key elements of the reform was
the establishment of community health care centers,
called EBAIS (abbreviation in Spanish for "Basic Inte-
grated Health Care Teams"), in different urban and rural
settings. The area covered by each EBAIS has an average
population of 2,500 to 7,000 inhabitants. These commu-
nity health centers are staffed with at least a physician, a
nurse, and a community health worker; several EBAIS may
receive also professional support from an additional team
composed of another physician, another nurse, a social
worker, a dentist, a nutritionist, a pharmacist, a micro-
biologist, and a medical records technician [14].
The opening of EBAIS allowed the Government to reor-
ganize the structure of the public health care system. TheBMC International Health and Human Rights 2008, 8:5 http://www.biomedcentral.com/1472-698X/8/5
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community health centers are a key component in
improving access to primary health care services, since
they were first established to serve patients living in rural
areas or in poor neighborhoods [13,14]. These commu-
nity health centers provide outpatient services (preventive
services and health promotion), while clinics and hospi-
tals provide primary, secondary and tertiary health care,
although they are specialized on the last two types of care:
inpatient and more specialized outpatient health care
(like surgeries, cancer treatment, intensive care units, or
emergencies). Community health centers seek to rational-
ize resource allocation by referring only those patients
who need specialized treatment to specialists in clinics
and hospitals. In this sense, they serve as "gate-keepers"
for the whole public system. In the past, outpatient visits
for chronic disease control were held only in clinics and
hospitals. Nowadays, EBAIS have also assumed this kind
of consultations as part of their mission of delivering pre-
ventive services [14].
Private health care providers deliver the same health care
services as the public system, although there is no integra-
tion among providers of primary, secondary, and tertiary
health care. Besides, private health care services are not
organized into health care management programs. Diabe-
tes education and community preventive programs are
rare in the private sector, and this is a major difference
between both types of providers. The other major differ-
ence is the existence of waiting lists in the public system.
While patients at public clinical settings have to wait as
much as several months (or even years) for an appoint-
ment (especially if the appointment is aimed for routine
check-ups or laboratory exams), services at private settings
are more timely and readily available [14]. Still, a Costa
Rican who receives health services at public health centers
has gone on average 5.4 times per year to outpatient serv-
ices, but Costa Ricans that receive services at the private
sector have gone on average 3.8 times per year to outpa-
tient visits. The difference is greater among people who
have been hospitalized. Among them, the average number
of days stayed at a public hospital is 12.6 days and, at a
private hospital, it is 5.6 days [15]. In general, access and
coverage in the private sector can not be compared to
access and coverage in the public sector, since the services
of the latter are basically free to all affiliates but affected
by long waiting lists, while access and coverage in the pri-
vate sector depend entirely on purchasing power.
Even though achievements of the Costa Rican health sec-
tor reform (which has not yet finished) have been docu-
mented [12-14,16], chronic disease management for
elderly patients has proved difficult for the public health
care system. The system has very high coverage in services
aimed to pre-natal care and children (e.g., DPT vaccina-
tion = 90%, births delivered in the public system that had
pre-natal care = 93%), but only 57% of the elderly popu-
lation and 84% of the total population with DM received
some kind of treatment at any of the public system's pri-
mary health care facilities during 2005 [16].
A way of exploring how well community health centers
are carrying out the task of providing DM-related preven-
tive services to the elderly is by comparing levels of meta-
bolic control across health care settings. As previously
explained, public hospitals and clinics provide outpatient
services, but they are aimed to treat cases that need more
specialized treatment, while EBAIS are supposed to work
as "gate-keepers" providing basic primary health care to
patients, before they are remitted to specialists. Patients
that receive outpatient services at public hospitals and
clinics are expected to be a selected population that needs
specialized treatment. A working hypothesis is that, under
the current health care system in Costa Rica, patients
whose last outpatient visit was at an EBAIS have metabolic
control at least as good as patients who had their last out-
patient visit at a secondary or tertiary level service (hospi-
tals and clinics). If metabolic control is inferior among
community health center patients than among hospital or
clinic patients, then this can be interpreted as evidence of
limitations in chronic disease management in the public
primary health care system.
This article has two goals. The first is to assess the level of
metabolic control among the diabetic elderly population
in Costa Rica, following the standards proposed by the
American Diabetes Association (ADA) [17]. This goal is
important for the Costa Rican and Latin American context
because there is very little research in the region that meas-
ures metabolic control in a nationally representative sam-
ple of the diabetic population. The second is to test
whether diabetic elderly patients of community health
centers have elevated levels of metabolic control that are
different from levels of patients from other health care set-
tings in Costa Rica. Metabolic control among diabetic
patients is then utilized as an indicator of the efficacy of
treatment that the physician prescribes to the patients
[17]. The results regarding the second goal will shed light
on whether the health sector reform is adequately
responding to the increasing burden of highly prevalent
chronic diseases among the elderly population.
Methods
Data collection
The Costa Rican Study on Longevity and Healthy Aging
(CRELES, for its name in Spanish) is an on-going longitu-
dinal study of a nationally representative sample of 2,827
adults born in 1945 or before (ages 60 and over at the first
interview) and residing in Costa Rica in the year 2000. The
data used in this article refer to the first wave of interviews,
conducted from November 2004 through SeptemberBMC International Health and Human Rights 2008, 8:5 http://www.biomedcentral.com/1472-698X/8/5
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2006. This sample size was obtained from a two-step pro-
cedure. First, an original sample of 9,600 individuals was
randomly selected from the 2000 census database with
stratification by 5-year age groups, with oversampling of
older individuals. Sampling fractions ranged from 1.1%
among those born in 1941–45 to 100% for those born
before 1905. In a second step, an in-depth longitudinal
study was carried out in a sub-sample of 60 "health areas"
(out of 102 for the whole country), selected from the
"mother sample" with probability proportional to the
population ages 60 and over. This sub-sample included
near 4,700 individuals. The sub-sample, which covers
59% of Costa Rican territory, yielded the following non-
response rates: 19% deceased by the contact date, 18%
not found in the field, 2% moved to other addresses, 2%
declined to be interviewed, 2% pendant interviews after
several visits (likely rejections). After all these types of
non-response are taken into account, the final sample is
2,827 participants. From those interviewed: 95% pro-
vided blood sample, 91% had anthropometric measures,
and 24% required a proxy to answer the questionnaire.
The in-depth interview addresses topics such as: self-
reported health status, functional limitations, household
characteristics, utilization of health care services, insur-
ance and working status, inter-generational transfers, and
demographic characteristics. All data and specimens in
the study were collected at the participants' homes, usu-
ally during two visits, using Personal Digital Assistants
(PDAs), also known as palm computers, with software
applications developed by Centro Centroamericano de Pob-
lacion (CCP) for this study. In the first visit, participants
provided informed consent for the interview and
answered a 90-minute long questionnaire (including
some mobility tests and two blood-pressure measures) as
well as a 10-minute food frequency questionnaire to trace
the intake of specific nutrients. The interviewer also asked
permission to check all medication prescribed by a health
care professional. In a second visit early the next day, fast-
ing blood samples were collected by venipuncture: 1
EDTA purple top tube (for 3–4 ml. of whole blood) and 2
serum separating tubes (SST) with a clot activator (for 10–
12 ml. of blood, to obtain 4–6 ml. of serum). Specimens
were analyzed in several laboratories according to the
methods described elsewhere [18]. Linear adjustments
were performed to have comparable measurements across
laboratories; technical support for the adequacy of these
linear adjustments was provided by microbiologists. LDL
levels were computed using the Friedewald equation [19].
DBP and SBP were computed as the mean of two inde-
pendent measurements of blood pressure taken during
the interview at rest position, with a planned interval of
20 minutes from one another.
Population and dependent variable definition
The subclass of elderly patients with DM is defined as
respondents that answer yes to the question: "Has a doc-
tor or medical personnel ever told you that you have dia-
betes or high blood sugar levels?" With this question, it is
impossible to determine whether the patients have Type I
or Type II DM. However, all respondents were diagnosed
after age 30, and have survived until at least age 60; there-
fore, it is likely that most if not all of them have Type II
DM. The size of the subsample based on the answer to the
above question is 542 individuals, 503 of them with
blood sample and valid data for assessing their metabolic
control. Since this paper focuses only on people diag-
nosed with DM, the analyses in this article are performed
on this subsample.
Metabolic control is studied by recording levels in gly-
cated hemoglobin (HbA1C), diastolic and systolic blood
pressure (DBP and SBP), low-density lipoprotein (LDL)
cholesterol, high-density lipoprotein (HDL) cholesterol,
and triglycerides. Elevated levels of each biomarker are
defined according to the standards recommended by the
ADA; therefore, elevated levels are: HbA1C ≥ 7%, DBP ≥
130 mmHg, SBP ≥ 80 mmHg, LDL ≥ 100 mg/dl, HDL ≤ 40
mg/dl, and triglycerides ≥ 150 mg/dl. High blood pressure
is defined when DBP ≥ 130 mmHg and SBP ≥ 80 mmHg
[17].
Three more response variables that refer to preventive
practices are analyzed: regular aspirin intake, having been
vaccinated against influenza during the last year, and hav-
ing visited a physician at least once in the past year for DM
control. Information for these variables is taken from
direct answers to questions in the survey instrument. Pro-
portions calculated from the two response variables just
listed above are considered as indicators of problems in
DM quality care, based on standards of the National Dia-
betes Quality Improvement Alliance measurement set
[20].
Independent variable definition
The main independent variable is derived from self-
reported answers to the question: "Where did you have
your last outpatient visit?" Since very few observations
were in the categories "private hospital", "private clinic",
and "private physician office", these were merged into the
single category "private clinical setting."
Potentially confounding variables are derived also from
direct answers to the questionnaire by respondents or
their proxy respondents: sex, age, income, years of educa-
tion, region of residence, having health insurance, history
of stroke, history of heart attack, smoking, and years since
DM diagnosis. Obesity, another potential confounder, is
defined as having a body mass index (BMI) higher thanBMC International Health and Human Rights 2008, 8:5 http://www.biomedcentral.com/1472-698X/8/5
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30. BMI was estimated using information on weight in kil-
ograms (kg) divided by height squared in squared meters
(m2). Weight and height were measured by the interview-
ers usually during the second visit with an estadiometer
(214 Seca Road Rod, Quickmedical) for height and a scale
(LifeFource, model UC321P, A&D medical) for weight
brought by the interviewer. Standard procedures are used
by every interviewer to minimize or avoid measurement
bias. Analyses also control for caloric intake, which is esti-
mated from answers to a questionnaire on frequency of
consumption of about 30 food-tracer items.
Statistical analysis
Statistical analysis is conducted using STATA SE version
9.0 (Stata Corporation, 2006). Descriptive statistics
include proportions for categorical variables, and means
and standard deviations for continuous variables. Ninety-
five percent confidence intervals are reported for univari-
ate descriptive statistics. Using logistic regressions to con-
trol for confounders, the effect of health care settings on
metabolic control are analyzed computing odds ratios. All
statistical analyses take into account differential sampling
weights.
Ethics clearance
The University of Costa Rica Ethics Committee approved
the procedure for collecting data and the informed con-
sent form. Institutional Review Boards at the University of
California-Berkeley and at the University of Wisconsin-
Madison reviewed the approval so members of these Uni-
versities could participate in the project.
Results
Descriptives
Metabolic control may depend not only on health seeking
behaviors and treatment compliance by diabetic patients,
but also on DM risk factors. According to Table 1, the dia-
betic population age 60 and above in Costa Rica has a rel-
atively low prevalence of some of these risk factors.
Obesity among Costa Rican elderly with DM is around
34%; merely 6% are currently smoking. Only 6% have
had a stroke before the interview, and 8% have had a heart
attack. Regarding characteristics related with access to
health care services, health insurance coverage is almost
universal for the Costa Rican elderly: 96% report having
health insurance. This high health insurance coverage
contrasts with the low socio-economic status (SES) that
these cohorts have, given that more than half of older per-
sons in Costa Rica have less than 6 years of education and
more than a third of this population have a monthly
income of $100 or less (its own if not married, or the aver-
age of the couple's monthly income if married).
As mentioned before, health care in Costa Rica is provided
predominantly by the public network of hospitals, clinics,
and community health centers. As illustrated in Table 2,
81% of the diabetic population report having their last
outpatient visit at a public health care setting. Addition-
ally, although 4% of elderly diabetic patients report to
have their last outpatient visit at home, it is very likely that
some of them were attended by health professionals from
EBAIS, as part of their community home visits.
Levels of metabolic control
Mean levels of biomarkers used as indicators of metabolic
control are very close to the endpoints defined as stand-
ards by the ADA, which signals that an important propor-
tion of the diabetic elderly population in Costa Rica is not
having proper metabolic control. As seen from Table 3,
glycemic control, as measured by HbA1C levels, seems to
be inadequate among 37% of the diabetic elderly. Most
also have elevated blood pressure levels. Also indicating
high risk, 78% have LDL cholesterol levels above or equal
to 100 mg/dl, and 70% have HDL cholesterol levels below
Table 2: Place of last outpatient visit among diabetic population 
age ≥ 60 in Costa Rica, 2004–2006 (n = 542).
%
Total 100.0
Public hospital 23.8
Public clinic 23.8
EBAIS 33.4
Private hospital, clinic or physician office 13.2
Patient's home 4.0
Other 1.6
Unknown 0.2
Table 1: Characteristics of the diabetic population age ≥ 60, 
Costa Rica, 2004–2006. (n = 542)
Characteristics %
Prevalence of self-reported DM diagnosis 20.8
% Females 61.2
% age 60–69 y.o. 54.0
% age 70–79 y.o. 35.8
% age ≥ 80 y.o. 10.3
% w/6 years or more of schooling 46.8
% w/couple's or individual's income < $100 per month 35.4
% living in Metropolitan capital city 54.0
% w/health insurance 95.7
% w/history of stroke 5.7
% w/history of heart attack 7.9
% w/body mass index (BMI) ≥ 30 Kg/m2 33.6
% currently smoking 6.1
% w/oral medication for DM 69.4
% w/insulin injections 31.0
% diagnosed 0–4 years ago 32.5
% diagnosed 5–9 years 18.2
% diagnosed 10 or more years 47.3
% with year of diagnosis unknown 2.0BMC International Health and Human Rights 2008, 8:5 http://www.biomedcentral.com/1472-698X/8/5
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or equal to 40 mg/dl. The proportion with elevated triglyc-
eride levels (48%) is slightly lower.
Regarding preventive behaviors, more than half of the dia-
betic elderly in Costa Rica are taking aspirin to prevent
cardiovascular events, and also less than half were vacci-
nated against influenza during the last year. There seems
to be close contact between diabetic patients and their
physicians, given that only 10% lack a diabetes-related
examination by their physician at least once a year. Note
that sample sizes are uneven across metabolic control
indicators, because there were some blood specimens
with problems for computing levels of HbA1C, Triglycer-
dies, LDL, and HDL.
Variation in the standards for HbA1C
Given that the target population in this analysis is com-
prised of elderly Costa Ricans with DM, it is important to
acknowledge that ADA standards might be too strict or
aggressive as clinical goals, that higher levels of HbA1C
and blood pressure might not be harmful and might even
be beneficial for elderly diabetic patients, and that reduc-
tion in these biomarker levels might be more important in
improving a patient's health than just the absolute target
[21-25]. Raising the cutoff points diminishes the preva-
lence of poor control considerably Table (4). If HbA1C ≥
9% defines poor glycemic control, instead of HbA1C ≥ 7%,
prevalence of poor glycemic control decreases in more
than half (15% vs 37%). Similar reductions are observed
if elevated SBP is defined as SBP ≥ 150 mmHg instead of
SBP ≥ 130 mmHg (42% vs. 78%), and if DBP is defined as
DBP ≥ 90 mmHg instead of DBP ≥ 80 mmHg (33% vs.
66%). The proportion of diabetic elderly with elevated
HbA1C and DBP levels is significantly lower (p < 0.05)
among people age 75 or more than among people ages 60
to 74. These figures match with previous conclusions that
Table 3: Levels of metabolic control biomarkers for diabetic population age ≥ 60, Costa Rica, 2004–2006.
Metabolic control indicators (n) 95% CI
Mean (SD)
HbA1C (%) 503 7.0 (1.8) (6.8- 7.2)
SBPa (mmHg) 539 148.2 (23.4) (146.0- 150.4)
DBPa (mmHg) 539 84.6 (12.4) (83.4- 85.8)
Triglycerides (mg/dl) 516 179.9 (110.0) (169.4- 190.4)
LDL (mg/dl) 463 131.1 (39.5) (126.8- 135.4)
HDL (mg/dl) 516 41.2 (11.7) (40.0- 42.4)
(%)
HbA1C ≥ 7% 503 36.9 (31.8- 41.9)
HbA1C ≥ 6.5% 503 52.1 (46.9- 57.3)
SBP ≥ 130 mmHga 539 78.2 (74.0- 82.4)
DBP ≥ 80 mmHga 539 65.9 (61.2- 70.6)
SBP ≥ 130 mmHg & DBP ≥ 80 mmHga 539 61.7 (56.8- 66.5)
Triglycerides ≥ 150 mg/dl 495 47.5 (42.3- 52.8)
LDL ≥ 100 mg/dl 463 78.3 (73.8- 82.8)
HDL ≤ 40 mg/dl 516 70.2 (65.5- 75.0)
Without aspirin intake 525 39.9 (34.9- 44.8)
Without influenza vaccine last year 537 45.9 (40.8- 51.0)
Without physician examination at least once a year 537 10.2 (7.1- 13.3)
Note: a/Arithmetic mean of two measurements
Table 4: Proportion with poor levels in metabolic control, by 
age, using different endpoints.
Metabolic control indicators Age
Total 60–74 75 or more
HbA1C
≥ 7% 36.9 39.4 28.9
≥ 8% 21.8 24.0 15.1
≥ 9% 14.8 17.0 7.8
SBP
≥ 130 mmHg 78.2 77.6 79.9
≥ 140 mmHg 62.2 61.1 65.7
≥ 150 mmHg 41.8 41.1 44.0
DBP
≥ 80 mmHg 65.9 69.4 55.1
≥ 85 mmHg 50.9 54.2 40.8
≥ 90 mmHg 33.0 36.4 22.6BMC International Health and Human Rights 2008, 8:5 http://www.biomedcentral.com/1472-698X/8/5
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most diabetic elderly in Costa Rica have adequate glyc-
emic control, but are very likely to have high blood pres-
sure levels. Multivariate models in the next section are
also estimated using these different cutoff points, but
results are not presented in tables unless the conclusions
are different from analyses using ADA standards.
We do not present analyses with different endpoints for
lipid control because the ADA standards are also recom-
mended by the National Cholesterol Education Program
Adult Treatment Panel III [26], given that older persons
with DM are considered at high risk of cardiovascular dis-
ease. Therefore, ADA standards are not considered as too
aggressive.
Differences in metabolic control across health care 
settings
In bivariate analyses that do not control for confounders,
based on χ2 likelihood-ratio tests of homogeneity, differ-
ent health care settings show significant differences in just
two control indicators: triglycerides (p < 0.01) and lack of
annual physician examination (p < 0.10) (Table 5).
Regarding the latter condition, patients that had their last
outpatient visit at a private clinical setting or at their own
home are less likely to have such periodic visits. However,
in terms of triglyceride control, elderly patients who had
their last visit at a community health center or at home are
more likely to have triglycerides ≥ 150 mg/dl. The differ-
ence is observed even among patients with prescribed
HMG-CoA reductase inhibitors (statins, the most com-
mon medication for lipid control observed in the sam-
ple). This result contrasts with what is observed with
HbA1C, hypertension, HDL, or LDL control, since propor-
tions with poor levels in these biomarkers are very similar
across health care settings with no statistically significant
differences. The absence of significant differences persists
even after observing patients with different patterns of
treatment, as observed in Table 5, among people pre-
scribed with insulin, with oral hypoglycemic medication,
or with antihypertensive medication.
In order to test whether there is confounding effect in
these bivariate relationships, one logistic regression for
each metabolic control indicator was estimated. Patients
who had their last outpatient visit at home are excluded
from the analyses because their corresponding sample
size is very small (20 persons or less, depending on the
indicator). Odds ratios for poor metabolic control levels
estimated with the regression models are net of the effect
of the characteristics described in Table 1. Controlling for
age-one of the variables in the analysis-is important
because clinical goals for metabolic control can vary
according to patients' age.
Results, shown in Table 6, confirm what was observed pre-
viously. There are no significant differences in the preva-
lence of poor levels of HbA1C, SBP, DBP, BP, and HDL, at
the community health center when compared to the other
Table 5: Proportion with poor levels in metabolic control, by place of last outpatient visit.
Metabolic control indicators Public hospital (%) Public clinic (%) Comm. health centers (%) Private clinical setting (%) Patient's home (%) χ2 p-value
HbA1C ≥ 7% 36.5 33.6 38.4 43.0 28.9
-People with insulin (n = 154) 53.3 47.4 68.6 54.5 42.3
-People with oral medication (n = 346) 38.5 29.3 35.9 47.0 32.0
SBP ≥ 130 mmHga 82.7 74.8 78.3 80.2 68.5
-People with antihypertensive medication 
(n = 358)
81.1 73.2 84.3 75.3 72.0
DBP ≥ 80 mmHga 66.2 66.1 66.0 70.0 50.0
-People with antihypertensive medication 
(n = 358)
63.4 60.3 66.8 74.1 52.1
SBP ≥ 130 & DBP ≥ 80 mmHga 64.4 63.3 60.1 62.1 48.8
-People with antihypertensive medication 
(n = 358)
61.8 58.8 65.2 65.9 52.1
Triglycerides ≥ 150 mg/dl 42.5 39.9 56.6 33.6 63.6 ***
-People with statin medication (n = 126) 49.6 40.3 71.3 32.0 73.6 **
LDL ≥ 100 mg/dl 72.7 79.9 84.0 66.8 70.1
-People with statin medication (n = 112) 77.7 79.8 84.3 47.7 84.4
HDL ≤ 40 mg/dl 68.9 75.6 70.1 62.4 62.9
Without aspirin intake 33.9 43.9 39.1 46.6 35.8
Without influenza vaccine last year 43.0 49.1 42.7 59.7 40.8
Without physician examination at least 
once a year
13.3 5.6 8.4 19.5 19.4 *
Notes: *: p < 0.10, **: p < 0.05, ***: p < 0.01
a/Arithmetic mean of two measurementsBMC International Health and Human Rights 2008, 8:5 http://www.biomedcentral.com/1472-698X/8/5
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health care settings. Results are robust to different patterns
of medication therapy, although poor glycemic control is
higher in community health center patients than in public
clinics and hospitals, when only patients treated with
insulin are analyzed (p < 0.10). Elderly diabetic patients
treated at public clinics (but not at public hospitals) and
at private clinical settings are less likely to have triglycer-
ides  ≥ 150 mg/dl, than patients treated at community
health centers. The multivariate analyses also show that
poor levels of LDL cholesterol are also less common
among patients of public hospitals and private outpatient
services, than at community health centers. These differ-
ences across health care settings seem to be larger when
only patients with prescribed statin medication are
observed, although the sample size is too small to have an
acceptable level of statistical power (more than 80%).
Interestingly, among people that visit private clinical set-
tings, frequency of having a DM related examination by a
physician seems to be inadequate since they do not report
to have at least one physician examination per year.
Another conclusion drawn from the multivariate models
(results not shown in the tables) is that DM duration is
associated only with elevated levels of HbA1C and lack of
physician examination during the last 12 months. People
who were diagnosed more than 4 years ago are twice as
likely to have HbA1C ≥ 7% as people with more recent
diagnosis. On the other hand, patients with more recent
diagnosis are also more likely to lack a DM-related physi-
cian examination during the last 12 months. Whether this
latter finding is due to the problem of waiting lists in the
public health care system is not clear.
Why are community health centers having higher propor-
tions of diabetic elderly patients with high triglycerides
and LDL levels? The survey instrument has questions
about when was the last time respondents have their cho-
lesterol levels measured. Besides, as mentioned before,
the questionnaire recorded all prescribed medication that
respondents were taking. We thus have data to test
whether elevated levels in triglycerides and LDL in EBAIS
patients come from lack of periodic cholesterol examina-
tion, from differences in type of medication, or from both
(Table 7). There are statistically significant differences in
the proportions of diabetic elderly patients having their
last cholesterol level measured during the last 6 months
across health care settings (χ2 likelihood-ratio homogene-
ity test, p < 0.05). However, people who attended commu-
nity health centers are more likely to have this test,
especially when compared to people at private clinical set-
Table 6: Odds ratios for poor levels of metabolic control by place of last outpatient visit.
Metabolic control indicators (n) Community health centers Public clinic Public hospital Private clinical setting
HbA1C ≥ 7% 460 1.00 0.93 0.84 1.40
-People with insulin 134 1.00 0.32 * 0.34 * 0.25
-People with oral medication 321 1.00 0.75 1.14 2.03
SBP ≥ 130 mg/dlb 479 1.00 0.82 1.28 1.22
-People with antihypertensive medication 321 1.00 0.51 0.80 0.43
DBP ≥ 80 mg/dlb 479 1.00 1.21 1.11 1.65
-People with antihypertensive medication 321 1.00 0.83 1.02 1.47
SBP ≥ 130 & DBP ≥ 80 mmHgb 479 1.00 1.34 1.33 1.30
-People with antihypertensive medication 321 1.00 0.86 1.01 1.02
Triglycerides≥ 150 mg/dl 452 1.00 0.51 ** 0.63 0.40 **
-People with statin medication 99 1.00 0.38 0.32 0.17 *
LDL ≥ 100 mg/dl 423 1.00 0.72 0.40 ** 0.27 ***
-People with statin medication 76 1.00 0.15 0.20 0.01 ***
HDL ≤ 40 mg/dl 472 1.00 1.63 1.17 0.85
Without aspirin intake 471 1.00 1.05 0.80 1.10
Without influenza vaccine last year 478 1.00 1.40 1.17 1.62
Without physician examination at least once a year 478 1.00 0.95 1.09 7.10 **
Notes: a/Odds ratios computed from logistic regressions that control for sex, age, income, schooling, region of residence, health insurance, history 
of stroke, history of heart attack, smoking, obesity, and years since diagnosis of DM. The odds ratios for biomarkers are also controlled for 
estimated caloric intake. Analyses exclude interviewees who had their last outpatient visit at home, because sample size for that category is too 
small.
b/Arithmetic mean of two measurementsBMC International Health and Human Rights 2008, 8:5 http://www.biomedcentral.com/1472-698X/8/5
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tings. Finally, there are no statistical differences in the pro-
portions having HMG-CoA reductase inhibitors (statin)
medication. Adding these variables in the logistic regres-
sions does not modify the size of the estimated odds ratios
reported before; estimating models with other nutritional
variables, such as carbohydrate intake or fat consumption
or oil used for cooking, or accounting for hypertensive
medication (which can alter lipids laboratory results) do
not change the size of the odds ratios either (results not
shown). Therefore, higher prevalence of elevated triglycer-
ide and LDL levels among community health center
patients does not seem to be explained by differences in
medication or in frequency of periodic cholesterol-related
examination. Given that estimated logistic regressions
control for caloric intake, smoking, age, sex, obesity,
region of residence, education, income, and DM medica-
tion (insulin and oral medication intake), it is unlikely
that differences in distributions of this kind of character-
istics are the ones that are explaining the association
between triglyceride and LDL levels, and health care set-
tings.
Given the concern posed above about how ADA standards
might be too burdensome or strict as clinical goals for dia-
betic older patients, the logistic models of this section are
also estimated using the different cutoff points shown in
Table 3 for HbA1C, SBP, and DBP. Compared to the origi-
nal models with ADA standards, the size of the odds ratios
change, but the same conclusions are drawn: there are no
differences in the prevalence of poor levels of HbA1C, SBP,
and DBP across health care settings (results are not pre-
sented but can be provided upon request).
Discussion
The first goal of this article was to assess the levels of met-
abolic control among elderly diabetic population in Costa
Rica, using the guidelines of the ADA as a point of com-
parison [17]. Mean levels of HbA1C, HDL, and LDL, and
the proportion of patients having elevated levels in the
same biomarkers, seem high in a first look. However,
these are similar or even lower than those reported in
high-income populations in the U.S. [20,27-31], Ger-
many [32], Sweden [33], and France [34]. Elevated levels
of DBP and SBP are considerably higher than in the U.S.,
while mean levels of triglycerides are lower [20]. When
compared to another developing country, prevalence of
poor levels of HbA1C, DBP, triglycerides, and LDL are
lower in this Costa Rican population than in a slightly
younger population in Medellin, Colombia; only the pro-
portion of HDL ≤ 40 mg/dl was higher in Costa Rica than
in Medellin [35]. Preventive health behaviors are broadly
practiced among the Costa Rican older population with
DM: only 40% is not having aspirin therapy regularly, and
46% report not to have an influenza vaccine during the
last 12 months. Additionally, only 10% report not to have
had a diabetes examination by a physician during the last
year.
If less strict endpoints of HbA1C are used (8% or 9%
instead of 7%), the proportion of diabetic older patients
with poor glycemic control decreases considerably, and
this change strengthens the argument that, among Costa
Rican elderly, levels of metabolic control seem favorable.
Elevated BP levels among elderly Costa Ricans with DM
found in this study signals an important public health
problem in the country. The combination of hypertension
and DM yields very high total costs for the public health
care services [11]. Further research is needed to learn the
reasons for this poor hypertension control in Costa Rica,
especially because there are no differences across health
care settings. Preventive behaviors linked more strongly to
hypertension than to DM or to dyslipidemias should be
studied. Prevalence of high blood pressure in the general
elderly Costa Rican population is extremely high: 64%
among females and 55% among males [35]. DM patients
do not escape to this pattern. Given that cardiovascular
disease mortality is not high in this population, one won-
ders whether blood pressure distribution of other popula-
tions is applicable to Costa Rica [37]. High prevalence of
elevated blood pressure persists even if cutoffs for defin-
ing elevated SBP and DBP are raised to 150 mmHg and 90
mmHg respectively.
Aside from hypertension, Costa Rican elderly with DM do
not seem to perform worse at metabolic control than pop-
ulations in the industrialized world. Why are metabolic
control levels so favorable among this population? One
possible explanation is that Costa Ricans are commonly
inclined to preventive health behaviors. Palmer [38] doc-
uments that Costa Rica was, in 1914, one of the few Latin
American countries in which the goals of the Rockefeller
Foundation anti-hookworm campaign were achieved.
According to Palmer, the success of this campaign can be
Table 7: Proportion reporting cholesterol treatment, by place of last outpatient visit.
Lipid control indicators Public hospital Public clinic Community health center Private clinical setting χ2 p-value
Cholesterol test in last 6 months 86.8 88.6 94.9 77.7 **
Statin medication (current use) 20.1 22.8 24.1 28.8
Notes: *: p < 0.10, **: p < 0.05, ***: p < 0.01BMC International Health and Human Rights 2008, 8:5 http://www.biomedcentral.com/1472-698X/8/5
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explained by the active involvement of Government
employees and rural teachers, and the willingness of the
Costa Rican population to trust in these public workers.
Regarding more recent data, with a non-representative
sample of diabetic patients in San Jose, Costa Rica's capi-
tal, Firestone et al. found that the levels of DM-specific
knowledge were greater than in a sample of Spanish-
speaking U.S. Latinos in Starr County, Texas [39].
However, in general, achievements in health status in
Costa Rica have been linked to effective primary health
care services, provided mainly by public institutions and
with a strong commitment with equity [12-14]. Although
the Costa Rican government had a long tradition of pro-
viding those services (which was in part possible because
of the non-existence of military expenditures since the
1949 Constitution abolished the armed forces), in the
1970s there was a breakthrough with the opening of hun-
dreds of Rural Health Posts [4]. More recently, a health
sector reform launched in 1995 fostered the opening of
community health centers or EBAIS to improve the access
to primary health care services in underserved areas. It is
hard to tell whether this "Costa Rican model" can be
exported to other Latin American countries with much
larger or less integrated populations, weaker institutions
and fewer resources available for public health.
These free primary health care services have been key
mechanisms in the control of communicable diseases,
maternal mortality, and children malnutrition. Nonethe-
less, the epidemiologic transition accompanied with the
process of population aging [2,3] can bring changes that
occur faster than the institutional ability to respond to
them. This possible lag in institutional response may
undermine the efficacy of this kind of services, especially
in chronic disease management.
The article's first goal-the assessment of metabolic control
among the older population in Costa Rica-serves as an
introduction for the second goal: to study whether meta-
bolic control among EBAIS patients is different than met-
abolic control among patients at other health care
settings. The working hypothesis was that EBAIS older
patients with DM had metabolic control levels equal or
better than diabetic elderly patients at other clinical set-
tings because EBAIS are aimed to provide only primary
health care services, and patients who need specialists are
then referred to physicians at hospitals or clinics. The
present article shows that, among the elderly population
with DM in Costa Rica, there are no major differences in
poor metabolic control between patients from public hos-
pitals and clinics on one side, and patients from commu-
nity health centers on the other. However, community
health center patients are more likely to have elevated lev-
els of LDL and triglycerides. Since worse levels of meta-
bolic control are not found for the other studied
biomarkers (HbA1C, HDL, SBP, and DBP), these results
may mean that lipid control for elderly diabetic patients
at community health care centers is not as thoroughly
examined as at public hospitals and clinics, or at private
clinical settings, perhaps because many EBAIS lack labora-
tory facilities. No differences in lipid-control medication
intake or frequency of cholesterol examination were
found across clinical settings; besides, differences in trig-
lycerides and LDL levels are not explained by differences
in obesity or caloric intake, given that the multivariate
models control for the effect of these variables. These dif-
ferences may also be related to particularities in DM edu-
cation at community health centers.
It is important for the public health care system to address
the high levels of blood pressure as well as the poorer lipid
control among patients that go to EBAIS because these
community health centers aim to improve the access to
primary health care to underserved and poor populations,
and primary health care is an effective way of managing
chronic diseases such as DM by decreasing the need of sec-
ondary and tertiary health care services [40,41]. Even in
industrialized countries such as the U.S.A., community
health centers have been seen as an inexpensive way of
providing preventive services to underserved and poor
populations [31,42,43]. However, in terms of DM con-
trol, community health centers in other countries have
not always been successful [30,31,43].
The advanced stage of the epidemiological transition in
Costa Rica is happening in the context of a health sector
reform. The community health centers, a key component
of the reform, are increasingly providing primary health
care services to elderly patients with chronic disease. If the
system of community health centers in Costa Rica turns to
be successful in reducing the burden of both communica-
ble and chronic diseases, the Costa Rican health sector
reform can serve as an experiment for other health sector
reforms that international organisms are fostering in
developing and transitional countries [45].
It is also worth noting that there are no differences in met-
abolic control between patients treated at public services
and patients treated at private services, except in the fre-
quency of DM examination by physicians. Diabetic eld-
erly patients that visited a private outpatient service or that
were treated at their own house are more likely to lack
physician examination at least once a year. It is not clear
whether this difference is due to financial barriers or med-
ical practices, but the results should call the attention to
users and providers of private health care in Costa Rica.
The analysis in this paper is performed using data from a
nationally representative survey of elderly in Costa RicaBMC International Health and Human Rights 2008, 8:5 http://www.biomedcentral.com/1472-698X/8/5
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that gathers self-reported information, as well as biomar-
kers. This kind of dataset is rare in developing countries.
However, there are limitations in the data. An important
one is that the study relies on self-reported information
which might be affected by reporting bias. Diabetic
respondents in the survey were determined based on self-
reported answers to the question "Has a doctor or medical
personnel ever told you that you have diabetes or high
blood sugar levels?" This approach might overestimate
the size of the actual diabetic population, and introduce
biases in summarizing the outcome variables. If a physi-
cian ever told a person that she had impaired glucose tol-
erance or a one-time elevation in glucose, it is possible
that this non-diabetic person will answer "yes" to the
question in the survey instrument. We consider that it is
inconvenient to validate the self-reported diagnosis with
metabolic data because metabolic data is the outcome of
this article. Therefore, any correction based on the
biomarkers will bias upwards the prevalence of poor met-
abolic control. A way to explore the bias due to self-report
is by using complementary information. The survey
inquires about insulin use and other prescribed medica-
tion that respondents have in their house. Interviewers ask
to see all prescribed drugs and enumerate them. Thirteen
percent of the sample (weighted estimate) report not to be
taking insulin or oral medication and also lack diabetes-
related medication in their houses. If excluding this
group, results are roughly the same although the mean
levels of the biomarkers and the prevalence of poor meta-
bolic control are slightly higher than with the original
sample, but the differences are not statistically significant
(α = 0.10). The most important differences between the
two sets of results are that the difference in prevalence of
LDL  ≥ 100 mg/dl between community health center
patients and patients at other health centers widens, espe-
cially among patients with statin medication, and that the
percentage of elderly diabetic people without physician
examination during the last 12 months drops from 10%
to 4%. We decided not to exclude respondents without
DM medication from the analyses because, even though
some of them might be persons that do not have the dis-
ease, others might be diabetic patients that do not care
about the treatment for their illness. Therefore, the analy-
sis would be based on a selected population of people that
do care about controlling their disease. We do not report
the results based on this subsample that excludes these
potential non-diabetic respondents, but we can provide
them upon request.
The limitation due to self-reported data is also true for the
main explanatory variable, place of last outpatient visit, as
well as for most of the control variables. Reporting bias
may arise from people that identify community health
centers as clinics. Associated with this limitation, there is
the problem that the survey questionnaire asks for the
place of the last outpatient visit, but the questionnaire
inquires neither whether the person visited another health
care setting before the last outpatient visit, nor the reason
of the last outpatient visit. It is possible that an undeter-
mined proportion of the diabetic older population that
reported last outpatient visits might refer to consultations
about health problems other than DM-related. We believe
this lack of information would not introduce a strong bias
in the estimates, insofar as physicians are supposed to be
examining patients' DM control, regardless of the reason
for the visit. However, this kind of bias can not be dis-
carded.
Another data problem is its limited statistical power to
detect some differences, because the sample size of all DM
patients is just about 500. Given that the subsample size
of EBAIS patients is around 180, and the levels of meta-
bolic control at the EBAIS range from 38% to 84%
(depending on the indicator of metabolic control), the
logistic regressions estimated for the final analyses have a
statistical power of 0.80 to detect only odds ratios that are
larger than 1.75 (or smaller than 0.55) for most of the
biomarkers, and larger than 2.50 (or smaller than 0.30)
for annual physician examination. Statistical power
decreases even more when subsamples based on medica-
tion therapy are analyzed rather than the whole diabetic
subsample. Power calculations are based on formulas for
logistic regression analysis [46].
Conclusion
Levels of metabolic control among elderly population
with DM in Costa Rica are similar or better than levels
observed in industrialized countries. Nevertheless, unusu-
ally high levels of BP indicate a problem in hypertension
treatment among diabetic population age ≥ 60 years old.
High BP levels are similar across health care settings. The
study posed the hypothesis that poor metabolic control
was less likely to occur among community health center
patients than among patients from other clinical settings.
Prevalence of elevated levels of SBP, DBP, and HbA1C is
very similar across health care settings. Higher propor-
tions of people with elevated levels of triglycerides and
LDL at community health centers may indicate problems
of dyslipidemia treatment that are not observed in other
health care settings. These higher proportions do not
appear to be explained by differences in prescribed medi-
cation, frequency of lipid control by a physician, obesity,
or caloric intake. The establishment of community health
centers has been a key component of the health sector
reform carried out since 1995 in Costa Rica. Eliminating
these differences in metabolic control across health care
settings is important for the health care system in the
country because community health centers constitute a
means of democratizing access to primary health care toBMC International Health and Human Rights 2008, 8:5 http://www.biomedcentral.com/1472-698X/8/5
Page 12 of 13
(page number not for citation purposes)
underserved and poor areas, and because DM produces
high financial costs to the national health care system.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
GBC proposed the article's objectives, carried out the sta-
tistical analysis, and wrote the draft manuscript. LRB con-
ceived the CRELES study, directed its design, data
collection and data processing, managed it as PI, and
supervised the analyses. All authors read and approved
the final manuscript.
Acknowledgements
"Costa Rica: Estudio de longevidad y envejecimiento saludable (CRELES)" is 
a research project of the University of Costa Rica, conducted by the Cen-
tral American Center for Population (CCP) in collaboration with Instituto 
de Investigaciones en Salud and the laboratories of Hospital San Juan de 
Dios, and funding from Wellcome Trust Foundation. Principal Investigator: 
Luis Rosero-Bixby. Co-investigators: Xinia Fernandez and William H. Dow. 
Colaborating researchers: E Mendez, G Pinto, H Campos, K Barrantes, A 
Cubero, G Brenes, F Morales, MA San Roman and G Valverde. Technical 
and support staff: D Antich, A Ramirez, J Hidalgo, J Araya and Y Hernandez. 
Fieldwork staff: J Solano, J Palma, J Méndez, M Arauz, M Gomez, M Rod-
riguez, G Salas, J Vindas and R Patiño. Special thanks to Arodys Robles, 
Xinia Fernandez, Ericka Mendez, and Omer Gersten, as well as to the two 
reviewers, Martin Gulliford and John Piette, for their comments.
References
1. Omran AR: The epidemiologic transition: a theory of the epi-
demiology of population change.  Milbank Mem Fund Q 1971,
49:509-538.
2. Frenk J, Lozano R, Bobadilla JL: La transicion epidemiologica en
America Latina.  Notas Poblacion 1994, 22:79-101.
3. Palloni A, McEniry M, Wong R, Pelaez M: The tide to come: eld-
erly health in Latin America and the Caribbean.  J Aging Health
2006, 18:180-206.
4. Rosero-Bixby L: Socioeconomic development, health inter-
ventions, and mortality decline in Costa Rica.  Scand J Soc Med
1991:33-42.
5. Menéndez J, Guevara A, Arcia N, León EM, Marín C, Alfonso JC:
Enfermedades crónicas y limitación funcional en adultos
mayores: estudio comparativo en siete ciudades de América
Latina y el Caribe.  Rev Panam Salud Publica 2005, 17:353-361.
6. Aschner P: Diabetes trends in Latin America.  Diab/Metab Res
Rev 2002, 18:S27-S31.
7. Barceló A, Rajpathak S: Incidence and prevalence of diabetes
mellitus in the Americas.  Rev Panam Salud Publica 2001,
10:300-308.
8. Martorell R, Stein AD, Schroeder DG: Early nutrition and later
adiposity.  J Nutr 2001, 131:874S-880S.
9. Consulta a censos y grandes bases de datos estadísticas
[http://censos.ccp.ucr.ac.cr/]
10. Mackay J, Mensah G: The Atlas of Heart Disease and Stroke Geneva,
World Health Organization and Center for Disease Control and Pre-
vention; 2004. 
11. Morice A, Achío M: Tendencias, costos y desafíos para la aten-
ción de las enfermedades crónicas en Costa Rica.  Revistas de
Ciencias Administrativas y Financieras de la Seguridad Social 2003,
11:18-34.
12. Bertodano Id I: The Costa Rican health system: low cost, high
value.  Bull World Health Organ 2003, 81:626-627.
13. Rosero-Bixby L: Evaluacion del impacto de la reforma del sec-
tor salud en Costa Rica.  Rev Panam Salud Publica 2004, 15:94-103.
14. Organizacion Panamericana de la Salud: Perfil del sistema de servicios de
salud de Costa Rica San Jose, CR, OPS; 2004. 
15. Méndez-Chacón E, Cubero-Mata A, Brenes-Camacho G, Rosero-
Bixby : Fuentes de ingreso y demanda de servicios de salud de
la población adulta mayor en Costa Rica: Un estudio con
base en la Encuesta de Ingresos y Gastos y el Estudio de Lon-
gevidad y Envejecimiento Saludable (CRELES) 2006.  Paper
presented at the Symposium Costa Rica a la Luz de la Encuesta Nacional
de Ingresos y Gastos de los Hogares 2006 [http://www.ccp.ucr.ac.cr/cre
les/pdf/MendezENIG06WEB.pdf]. San Jose, Costa Rica
16. Caja Costarricense del Seguro Social CCSS: Estadisticas Generales de
los Servicios de Atención de Salud, 1980–2005 San Jose, CR, CCSS;
2005. 
17. American Diabetes Association: Standards of medical care in
diabetes-2006 (Position Statement).  Diabetes Care 2006,
29(Suppl 1):S4-S42.
18. Méndez-Chacón E, Rosero-Bixby L, Fernández-Rojas X, Barrantes-
Jiménez K: Comparación de los resultados de pruebas de lab-
oratorio seleccionadas de un estudio poblacional de adultos
mayores de Costa Rica.  Población y Salud en Mesoamérica Revista
electrónica 2007, 5:4.
19. Bairaktari ET, Seferiadis KI, Elisaf MS: Evaluation of methods for
the measurement of low-density lipoprotein cholesterol.  J
Cardiovasc Pharmacol Ther 2005, 10:45-54.
20. Saaddine JB, Cadwell B, Gregg EW, Engelgau MM, Vinicor F, Impera-
tore G, Narayan KM: Improvements in diabetes processes of
care and intermediate outcomes: United States, 1988–2002.
Ann Intern Med 2006, 144:465-474.
21. Aron DC, Pogach LM: One size does not fit all: the need for a
continuous measure for glycemic control in diabetes.  Jt
Comm J Qual Patient Saf 2007, 33:636-343.
22. Pogach LM, Brietzke SA, Cowan CL Jr, Conlin P, Walder DJ, Sawin
CT, VA/DoD Diabetes Guideline Development Group: Develop-
ment of evidence-based clinical practice guidelines for diabe-
tes: the Department of Veterans Affairs/Department of
Defense guidelines initiative.  Diabetes Care 2004, 27(Suppl
2):B82-B89.
23. Vijan S, Hofer TP, Hayward : Estimated benefits of glycemic con-
trol in microvascular complications in Type 2 Diabetes.  Ann
Intern Med 1997, 127:788-795.
24. Shekelle P, Vijan S: Quality indicators for the care of diabetes
mellitus in vulnerable elders.  J Am Geriatr Soc 2007, 55(Suppl
2):S312-S317.
25. Hayward RA: All-or-nothing treatment targets make bad per-
formance measures.  Am J Manag Care 2007, 13:126-128.
26. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunning-
hake DB, Pasternak RC, Smith SC Jr, Stone NJ, National Heart, Lung,
and Blood Institute, American College of Cardiology Foundation,
American Heart Association: Implications of recent clinical trials
for the National Cholesterol Education Program Adult
Treatment Panel III guidelines.  Circulation 2004, 110:227-239.
27. Wendel CS, Shah JH, Duckworth WC, Hoffman RM, Mohler MJ,
Murata GH: Racial and ethnic disparities in the control of car-
diovascular disease risk factors in Southwest American vet-
erans with type 2 diabetes: the Diabetes Outcomes in
Veterans Study.  BMC Health Serv Res 2006, 6:58.
28. Selvin E, Coresh J, Brancati FL: The burden and treatment of dia-
betes in elderly individuals in the U.S.  Diabetes Care 2006,
29:2415-2419.
29. Coon P, Zulkowski K: Adherence to American Diabetes Asso-
ciation standards of care by rural health care providers.  Dia-
betes Care 2002, 25:2224-2229.
30. Andrus MR, Kelley KW, Murphey LM, Herndon KC: A comparison
of diabetes care in rural and urban medical clinics in Ala-
bama.  J Community Health 2004, 29:29-44.
31. Chin MH, Auerbach SB, Cook S, Harrison JF, Koppert J, Jin L, Thiel F,
Karrison TG, Harrand AG, Schaefer CT, Takashima HT, Egbert N,
Chiu SC, McNabb WL: Quality of diabetes care in community
health centers.  Am J Public Health 2000, 90:431-434.
32. Samann A, Kaiser J, Hunger-Dathe W, Schiel R, Muller UA: Popula-
tion-based measurement of quality of diabetes care using
HbA1c values in the state of Thuringia/Germany.  Exp Clin
Endocrinol Diabetes 2004, 112:531-537.
33. Farnkvist LM, Lundman BM: Outcomes of diabetes care: a popu-
lation-based study.  Int J Qual Health Care 2003, 15:301-307.
34. Prevost G, Phan TM, Mounier-Vehier C, Fontaine P: Control of car-
diovascular risk factors in patients with type 2 diabetes andPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC International Health and Human Rights 2008, 8:5 http://www.biomedcentral.com/1472-698X/8/5
Page 13 of 13
(page number not for citation purposes)
hypertension in a French national study (Phenomen).  Diabe-
tes Metab 2005, 31:479-485.
35. Villegas-Perrasse A, Abad SB, Faciolince S, Hernandez N, Maya C,
Parra L, Rivas E, Vallejo P: El control de la diabetes mellitus y sus
complicaciones en Medellín, Colombia, 2001–2003.  Rev
Panam Salud Publica 2006, 20:393-402.
36. Méndez-Chacón E, Rosero-Bixby L: Prevalencia de hipertensión
en adultos mayores de Costa Rica.  Población y Salud en Mes-
oamérica Revista electrónica 5:3.
37. Rosero-Bixby L: Adult mortality decline in Costa Rica.  In Adult
mortality in Latin America Edited by: Timaeus IM, Chackiel J, Ruzicka L.
Oxford, UK: Clarendon Pres; 1995:166-195. 
38. Palmer S: From Popular Medicine to Medical Populism: Doctors, Healers,
and the Public Power in Costa Rica, 1800–1940 Durham: Duke Univ.
Press; 2003. 
39. Firestone DN, Jiménez-Briceño L, Reimann JO, Talavera GA, Polnsky
WH, Edelman SV: Predictors of diabetes-specific knowledge
and treatment satisfaction among Costa Ricans.  Diabetes Educ
30:281-292.
40. Fleming BB, Greenfield S, Engelgau MM, Pogach LM, Clauser SB, Par-
rott MA: The Diabetes Quality Improvement Project: moving
science into health policy to gain an edge on the diabetes epi-
demic.  Diabetes Care 2001, 24:1815-1820.
41. Salinas-Martinez AM, Sandoval-Espinosa D, Nunez-Rocha GM, Garza-
Elizondo ME, Villarreal-Rios E: Impacto de la atención ambulato-
ria del primer nivel de atención en la hospitalizacion de pob-
lación asegurada con diabetes mellitus tipo 2.  Aten Primaria
2002, 30:611-617.
42. Starfield B, Powe NR, Weiner JR, Stuart M, Steinwachs D, Scholle SH,
Gerstenberger A: Costs vs quality in different types of primary
care settings.  JAMA 1994, 272:1903-1908.
43. Lefkowitz B: The health center story: forty years of commit-
ment.  J Ambul Care Manage 2005, 28:295-303.
44. Chin MH, Cook S, Jin L, Drum ML, Harrison JF, Koppert J, Thiel F,
Harrand AG, Schaefer CT, Takashima HT, Chiu SC: Barriers to
providing diabetes care in community health centers.  Diabe-
tes Care 2001, 24:268-274.
45. Banco Mundial: Informe sobre el desarrollo mundial, 1993. Invertir en
salud Washington, DC: Banco Mundial; 1993. 
46. Hosmer DW, Lemeshow S: Applied Logistic Regression New York, NY,
John Wiley and Sons, Inc; 2000. 
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1472-698X/8/5/prepub